<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Xu Z</submitter><funding>High-level Talent Research Project of Shihezi University</funding><funding>National Natural Science Foundation of China</funding><funding>Talent Program 'Tianchi Talent (Young Doctor)' in Xinjiang Uygur Autonomous Region (CZ004336)</funding><funding>Major Scientific and Technological Projects of Corps</funding><pagination>e70223</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12420658</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(9)</volume><pubmed_abstract>The Brucella abortus A19 attenuated live vaccine poses potential infection risks during practical applications and interferes with serological diagnostics, thereby affecting quarantine measures and the establishment of disease-free zones. Consequently, this study aimed to reduce its potential virulence, enhance its protective efficacy and differentiate it from wild-type strains by knocking out the immunosuppressive virulence gene btpB in the A19 strain. Using homologous recombination, we successfully obtained the A19ΔBtpB deletion strain. In a mouse model, the A19ΔBtpB strain demonstrated improved safety and significantly increased TLR2 and TLR4 expression levels in splenic lymphocytes, suggesting attenuated immune suppression. The A19ΔBtpB strain induced Brucella-specific IgG antibodies c</pubmed_abstract><journal>Microbial biotechnology</journal><pubmed_title>A BtpB-Deleted Brucella Vaccine Strain Provides Dual Advantages: Enhanced Protection and Diagnostic Differentiation Capability in Mice.</pubmed_title><pmcid>PMC12420658</pmcid><funding_grant_id>U1803236</funding_grant_id><funding_grant_id>RCZK202456</funding_grant_id><funding_grant_id>2017AA003</funding_grant_id><funding_grant_id>CZ004336</funding_grant_id><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>He H</pubmed_authors><pubmed_authors>Ma Z</pubmed_authors><pubmed_authors>Gao H</pubmed_authors><pubmed_authors>Chen C</pubmed_authors><pubmed_authors>Yi J</pubmed_authors><pubmed_authors>Wu A</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Xu Z</pubmed_authors><pubmed_authors>Deng X</pubmed_authors><pubmed_authors>Xu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>A BtpB-Deleted Brucella Vaccine Strain Provides Dual Advantages: Enhanced Protection and Diagnostic Differentiation Capability in Mice.</name><description>The Brucella abortus A19 attenuated live vaccine poses potential infection risks during practical applications and interferes with serological diagnostics, thereby affecting quarantine measures and the establishment of disease-free zones. Consequently, this study aimed to reduce its potential virulence, enhance its protective efficacy and differentiate it from wild-type strains by knocking out the immunosuppressive virulence gene btpB in the A19 strain. Using homologous recombination, we successfully obtained the A19ΔBtpB deletion strain. In a mouse model, the A19ΔBtpB strain demonstrated improved safety and significantly increased TLR2 and TLR4 expression levels in splenic lymphocytes, suggesting attenuated immune suppression. The A19ΔBtpB strain induced Brucella-specific IgG antibodies c</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-03T05:42:14.956Z</modification><creation>2026-04-25T03:17:19.272Z</creation></dates><accession>S-EPMC12420658</accession><cross_references><pubmed>40926333</pubmed><doi>10.1111/1751-7915.70223</doi></cross_references></HashMap>